Evidence method
Level · gp.fundamentals.debt_to_revenue
145.28% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
HBIO · Mar 31, 2024
HARVARD BIOSCIENCE INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001171843-24-002618General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
2.63% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
5.72% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
-18.23% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
98.47% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
60.26% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-9.30% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
11.77% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
4.28% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History16 statesHistory building
Sep 30, 20220/8 normalizedLevel 3Dec 31, 20220/8 normalizedLevel 3Mar 31, 20230/8 normalizedLevel 3Jun 30, 20230/8 normalizedLevel 3Sep 30, 20230/9 normalizedLevel 3Dec 31, 20230/9 normalizedLevel 3Mar 31, 20240/9 normalizedLevel 3Jun 30, 20240/9 normalizedLevel 3Sep 30, 20248/9 normalizedLevel 3Dec 31, 20248/9 normalizedLevel 3Mar 31, 20258/9 normalizedLevel 3Jun 30, 20258/9 normalizedLevel 3Sep 30, 20259/9 normalizedLevel 3Dec 31, 20259/9 normalizedLevel 3Mar 31, 20269/9 normalizedLevel 3Jun 30, 20269/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 32.57%
- Current
- 145.28%
- Delta
- 112.70%
- Previous
- 1.59%
- Current
- 2.63%
- Delta
- 1.04%
- Previous
- 12.50%
- Current
- 5.72%
- Delta
- -6.77%
- Previous
- -0.96%
- Current
- -18.23%
- Delta
- -17.27%
- Previous
- 22.02%
- Current
- 98.47%
- Delta
- 76.45%
- Previous
- 58.86%
- Current
- 60.26%
- Delta
- 1.40%
- Previous
- 1.69%
- Current
- -9.30%
- Delta
- -10.98%
- Previous
- 10.48%
- Current
- 11.77%
- Delta
- 1.29%
- Previous
- 4.45%
- Current
- 4.28%
- Delta
- -0.18%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · HBIO Fundamental State →Has State · HARVARD BIOSCIENCE INC →Transitioned To · HBIO Fundamental State →Transitioned To · HBIO BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · HBIO CAPEX_INTENSITY_INCREASED →Transitioned To · HBIO CASH_GENERATION_DECREASED →Transitioned To · HBIO GROWTH_DECREASED →Transitioned To · HBIO INVENTORY_PRESSURE_INCREASED →Transitioned To · HBIO MARGIN_INCREASED →Transitioned To · HBIO PROFITABILITY_DECREASED →Transitioned To · HBIO R_AND_D_INTENSITY_INCREASED →Transitioned To · HBIO SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.